PDCD1 and cancer: Here we have first systematically analyzed extensive multiomic data to extract PD-1 and LAG-3 omic signatures in all TCGA cancers to compare with PD-1/LAG-3-associated signatures in T-cell lines with constitutive PD-1 and LAG-3 signaling.